Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33.21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence

This image opens in the lightbox

News provided by

Mordor Intelligence Private Limited

09 Apr, 2026, 07:57 GMT

Share this article

Share toX

Share this article

Share toX

HYDERABAD, India  , April 9, 2026 /PRNewswire/ -- According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected to grow to USD 23.53 billion in 2026, reaching an estimated USD 56.48 billion by 2031, registering a CAGR of 19.14% over the forecast period (2026–2031), driven by rapid advancements in genetic engineering, increasing demand for bio-based products, and expanding applications across healthcare, agriculture, and industrial biotechnology. The market is gaining momentum as organizations worldwide leverage synthetic biology to design and engineer biological systems for improved efficiency, sustainability, and innovation.

The synthetic biology market is being shaped by the growing use of engineered organisms in drug development, vaccine production, and gene therapies. The ability to manipulate DNA and create customized biological pathways is enabling breakthroughs in precision medicine and biopharmaceutical manufacturing. Increasing investments in research and development, along with strong collaboration between academic institutions and biotechnology companies, are further supporting market expansion. Industrial applications are also contributing significantly to market growth, with synthetic biology being used to produce biofuels, specialty chemicals, and sustainable materials. The shift toward environmentally friendly production methods is encouraging industries to adopt bio-based alternatives, reducing dependence on traditional chemical processes. Additionally, advancements in DNA sequencing, gene synthesis, and automation technologies are improving scalability and reducing production costs.

Synthetic Biology Market Share by Region

Asia-Pacific is emerging as a high-growth region due to expanding biotechnology capabilities, rising government support, and increasing adoption of synthetic biology across healthcare, agriculture, and industrial sectors.

North America represents a significant share of the synthetic biology market, driven by strong research funding, advanced biotechnology infrastructure, and the presence of leading industry players. The region continues to lead in innovation and commercialization of synthetic biology solutions.

Europe holds a notable market position, supported by increasing focus on sustainable development, government initiatives promoting bioeconomy strategies, and growing investment in biotechnology research.

Synthetic Biology Market Trends & Forecast

Growing Applications in Healthcare and Biopharmaceuticals

Synthetic biology is increasingly being used in the development of advanced therapeutics, vaccines, and gene-based treatments, supporting innovation in healthcare.

Rising Demand for Sustainable Bio-based Products

Industries are adopting synthetic biology to produce environmentally friendly alternatives, driving growth in biofuels, bioplastics, and specialty chemicals.

Soumya Goud, Senior Research Manager, Mordor Intelligence, says, "The synthetic biology market is advancing as organizations explore new approaches to production, healthcare, and sustainable materials. Mordor Intelligence applies a structured review of diverse data sources, offering a more balanced and comparable perspective than analyses with limited validation or narrower market coverage."

Synthetic Biology Market Segmentation Overview

By Product

  • Core Products
    • DNA/RNA Synthesizers
    • Gene Editing Kits & Enzymes
  • Enabling Products
    • Oligonucleotides
    • Cloning Vectors
  • Enabled Products
    • Cell-Free Systems
    • Engineered Micro-organisms

By Technology

  • Genome Engineering
  • DNA/RNA Synthesis
  • Bioinformatics & CAD Tools
  • Bioprocessing & Automation

By Application

  • Healthcare
    • Drug Discovery
    • Gene & Cell Therapy
  • Chemicals & Biofuels
    • Specialty Chemicals
    • Advanced Biofuels
  • Food & Agriculture
    • Alternative Proteins
    • Crop Trait Engineering
  • Other (Bio-security, Environment, Data Storage)

By End-User

  • Industrial Biotech Companies
  • Pharma & Biopharma
  • Academic & Research Institutes
  • Defense & Government Labs

By Geography

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East
    • GCC
    • South Africa
    • Rest of Middle East
  • South America
    • Brazil
    • Argentina
    • Rest of South America

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/synthetic-biology-market?utm_source=prnewswire

Synthetic Biology Market Competitive Outlook

The synthetic biology market features a mix of biotechnology companies, research organizations, and technology providers focusing on innovation, scalability, and commercialization of engineered biological solutions. Market participants are investing in advanced platforms, expanding research capabilities, and forming strategic partnerships to accelerate product development and market penetration.

Companies are prioritizing advancements in gene editing, automation, and data-driven biological design to strengthen their competitive positioning and address the growing demand for synthetic biology applications across industries.

Major companies in the synthetic biology include:

  • Genscript
  • Thermo Fisher Scientific Inc.
  • Amyris Inc.
  • Integrated DNA Technologies Inc. (Danaher Corporation)
  • Illumina, Inc.

Industry Related Reports by Mordor Intelligence

Microbiome Sequencing Services Market Size  - The microbiome sequencing services market is estimated at USD 1.94 billion in 2026 and is projected to reach USD 2.68 billion by 2031, registering a CAGR of 6.63% during the forecast period. Growth is driven by increasing research in microbiome-based therapeutics, rising interest in gut health studies, and expanding applications in clinical and environmental research.

Merieux Nutrisciences, Microbiome Insights, MR DNA, Baseclear and Clinical Microbiomics are the major companies operating in this market.

Read more about companies in the microbiome sequencing services market: https://www.mordorintelligence.com/industry-reports/microbiome-sequencing-services-market/companies?utm_source=prnewswire

DNA Methylation Market Share  - The DNA methylation market stood at USD 2.95 billion in 2025 and is expected to reach USD 3.74 billion by 2030, growing at a CAGR of 4.8% during the forecast period. Market expansion is supported by increasing focus on epigenetics research, rising applications in cancer diagnostics, and growing adoption of methylation-based biomarker studies.

Cell-Free Protein Expression Market Analysis  - The cell-free protein expression market is estimated to grow from USD 339.72 million in 2026 to USD 499.73 million by 2031, registering a CAGR of 8.02% during the forecast period. Growth is driven by increasing demand for rapid protein synthesis in research, rising applications in drug discovery, and expanding use in synthetic biology and functional genomics studies.

Thermo Fisher Scientific Inc., Promega Corporation, Merck KGaA (Sigma-Aldrich), Takara Bio Inc. and New England Biolabs are the major companies operating in this market.

Read more about companies in the cell-free protein expression market: https://www.mordorintelligence.com/industry-reports/cell-free-protein-expression-market/companies?utm_source=prnewswire

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

Modal title

Also from this source

Semiconductor Foundry Market to Cross USD 266B by 2031, Advancing at 7.61% CAGR, Reports Mordor Intelligence

Semiconductor Foundry Market to Cross USD 266B by 2031, Advancing at 7.61% CAGR, Reports Mordor Intelligence

According to the latest report by Mordor Intelligence, the semiconductor foundry market is poised for strong expansion over the coming years. The...

Unmanned Aerial Vehicles (UAV) Market Outlook 2026-2031, Led by the Fixed-Wing Segment with 74.78% Share in 2025 - Mordor Intelligence

Unmanned Aerial Vehicles (UAV) Market Outlook 2026-2031, Led by the Fixed-Wing Segment with 74.78% Share in 2025 - Mordor Intelligence

According to the latest report by Mordor Intelligence, unmanned aerial vehicles market size is set for steady expansion, growing from USD 17.23...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.